Lineage Cell Therapeutics, Inc. (LCTX)

CIK 876343 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lineage Cell Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 6, 20268-K0001193125-26-338020
Aug 6, 202610-Q0001193125-26-338064
Jul 29, 2026SCHEDULE 13G0002012383-26-002817
Jul 2, 202640001193125-26-294860
Jul 2, 202640001193125-26-294871
Jul 2, 202640001193125-26-294852
Jul 2, 202640001193125-26-294873
Jul 2, 202640001193125-26-294859
Jul 2, 202640000919574-26-004259
Jun 12, 20268-K0001193125-26-269557
May 12, 20268-K0001193125-26-219421
May 12, 202610-Q0001193125-26-219479
Apr 29, 2026DEFA14A0001193125-26-191616
Apr 29, 2026ARS0001193125-26-191714
Apr 29, 2026DEF 14A0001193125-26-191556
Mar 23, 2026EFFECT9999999995-26-000908
Mar 12, 202640001193125-26-104106
Mar 11, 2026S-30001193125-26-101168
Mar 11, 20268-K0001193125-26-101167
Mar 11, 2026424B50001193125-26-101166
Mar 6, 202640001193125-26-097185
Mar 6, 202640001193125-26-097184
Mar 6, 202640001193125-26-097181
Mar 5, 202610-K0001193125-26-093992
Mar 5, 20268-K0001193125-26-093948